Canada markets closed

Avidity Biosciences, Inc. (RNA)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
25.58-0.22 (-0.85%)
At close: 04:00PM EDT
25.53 -0.05 (-0.20%)
After hours: 06:37PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 2.47B
Enterprise Value 1.88B
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)197.04
Price/Book (mrq)4.93
Enterprise Value/Revenue 196.82
Enterprise Value/EBITDA -8.06

Trading Information

Stock Price History

Beta (5Y Monthly) 0.77
52-Week Change 3130.36%
S&P500 52-Week Change 323.57%
52 Week High 327.66
52 Week Low 34.82
50-Day Moving Average 322.57
200-Day Moving Average 311.89

Share Statistics

Avg Vol (3 month) 31.16M
Avg Vol (10 day) 3963.3k
Shares Outstanding 595.62M
Implied Shares Outstanding 695.62M
Float 867.98M
% Held by Insiders 16.37%
% Held by Institutions 184.57%
Shares Short (Apr 15, 2024) 410.66M
Short Ratio (Apr 15, 2024) 49.14
Short % of Float (Apr 15, 2024) 413.53%
Short % of Shares Outstanding (Apr 15, 2024) 413.37%
Shares Short (prior month Mar 15, 2024) 48.62M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-3,043.46%

Management Effectiveness

Return on Assets (ttm)-23.24%
Return on Equity (ttm)-39.34%

Income Statement

Revenue (ttm)9.56M
Revenue Per Share (ttm)0.13
Quarterly Revenue Growth (yoy)-20.80%
Gross Profit (ttm)N/A
EBITDA -233.5M
Net Income Avi to Common (ttm)-212.22M
Diluted EPS (ttm)-2.91
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)595.35M
Total Cash Per Share (mrq)7.47
Total Debt (mrq)9.85M
Total Debt/Equity (mrq)1.97%
Current Ratio (mrq)7.58
Book Value Per Share (mrq)6.32

Cash Flow Statement

Operating Cash Flow (ttm)-119.06M
Levered Free Cash Flow (ttm)-86.66M